Home/Filings/4/0001209191-23-021917
4//SEC Filing

Cummings Keith Lamont 4

Accession 0001209191-23-021917

CIK 0001746473other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 5:56 PM ET

Size

5.3 KB

Accession

0001209191-23-021917

Insider Transaction Report

Form 4
Period: 2023-03-29
Cummings Keith Lamont
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-03-29+19,375158,430 total
Footnotes (2)
  • [F1]On July 28, 2022, the Reporting Person was granted 77,500 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On March 29, 2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 19,375 shares.
  • [F2]Includes 631 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001809204

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 5:56 PM ET
Size
5.3 KB